{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:09:45Z","timestamp":1785168585959,"version":"3.55.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3836,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["SAF 03\/0586"],"award-info":[{"award-number":["SAF 03\/0586"]}],"id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["SAF 02\/03696"],"award-info":[{"award-number":["SAF 02\/03696"]}],"id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["C03\/02"],"award-info":[{"award-number":["C03\/02"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pfizer\/Pharmacia"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1002\/hep.20595","type":"journal-article","created":{"date-parts":[[2005,2,19]],"date-time":"2005-02-19T01:46:24Z","timestamp":1108777584000},"page":"579-587","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":75,"title":["Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites\u2020"],"prefix":"10.1097","volume":"41","author":[{"given":"Joan","family":"Cl\u00e0ria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"L\u00f3pez\u2010Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin\u00e9s","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Ruiz\u2010del\u2010Arbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Vucelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20250325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(79)90268-3","article-title":"Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease","volume":"77","author":"Boyer","year":"1979","journal-title":"Gastroenterology"},{"key":"R2-23-20250325","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jcem-48-6-895","article-title":"Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease","volume":"48","author":"Zipser","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-23-20250325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2362.1983.tb00100.x","article-title":"Sympathetic nervous activity, renin\u2010angiotensin system and renal excretion of prostaglandin E2 in cirrhosis: relationship to functional renal failure and sodium and water excretion","volume":"13","author":"Arroyo","year":"1983","journal-title":"Eur J Clin Invest"},{"key":"R4-23-20250325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/hep.1840030108","article-title":"Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis","volume":"3","author":"Mirouze","year":"1983","journal-title":"HEPATOLOGY"},{"key":"R5-23-20250325","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000183692","article-title":"Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites","volume":"42","author":"Quintero","year":"1986","journal-title":"Nephron"},{"key":"R6-23-20250325","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00000441-198709000-00007","article-title":"Reversible acute decrease in renal function by NSAIDs in cirrhosis","volume":"294","author":"Brater","year":"1987","journal-title":"Am J Med Sci"},{"key":"R7-23-20250325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(86)90912-5","article-title":"Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti\u2010inflammatory drugs in cirrhosis with ascites: an overview with emphasis on pathogenesis","volume":"81","author":"Arroyo","year":"1986","journal-title":"Am J Med"},{"key":"R8-23-20250325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1098-8823(03)00075-3","article-title":"Prostaglandins and other cyclooxygenase\u2010dependent arachidonic acid metabolites and the kidney in liver disease","volume":"72","author":"Cl\u00e0ria","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R9-23-20250325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.1984.136","article-title":"Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis","volume":"26","author":"P\u00e9rez\u2010Ayuso","year":"1984","journal-title":"Kidney Int"},{"key":"R10-23-20250325","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0016-5085(83)80119-X","article-title":"Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites","volume":"84","author":"Planas","year":"1983","journal-title":"Gastroenterology"},{"key":"R11-23-20250325","first-page":"232","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin\u2010like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature"},{"key":"R12-23-20250325","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1073\/pnas.89.9.3917","article-title":"Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme","volume":"89","author":"Masferrer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-23-20250325","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promoter\u2010inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue","volume":"266","author":"Kujubu","year":"1991","journal-title":"J Biol Chem"},{"key":"R14-23-20250325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0014-5793(93)80263-T","article-title":"Expression of mRNA for cyclooxygenase\u20101 and cyclooxygenase\u20102 in human tissues","volume":"330","author":"O'Neill","year":"1993","journal-title":"FEBS Lett"},{"key":"R15-23-20250325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","article-title":"Distinct functions of COX\u20101 and COX\u20102","volume":"68\u201069","author":"Morita","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R16-23-20250325","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo\u2010oxygenase\u20101 rather than cyclo\u2010oxygenase\u20102 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-23-20250325","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","article-title":"Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain","volume":"91","author":"Seibert","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-23-20250325","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1073\/pnas.95.22.13313","article-title":"Pharmacological analysis of cyclooxygenase\u20101 in inflammation","volume":"95","author":"Smith","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-23-20250325","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase\u20102 in vivo is anti\u2010inflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-23-20250325","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The Coxibs, selective inhibitors of cyclooxygenase\u20102","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"R21-23-20250325","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0016-5085(99)70020-X","article-title":"Selective inhibition of cyclooxygenase\u20102 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites","volume":"116","author":"Bosch\u2010Marc\u00e9","year":"1999","journal-title":"Gastroenterology"},{"key":"R22-23-20250325","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bjp.0704528","article-title":"Cyclooxygenase\u20101 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites","volume":"135","author":"L\u00f3pez\u2010Parra","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R24-23-20250325","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/cs0750263","article-title":"Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin\u2010aldosterone system","volume":"75","author":"Sol\u00e1","year":"1988","journal-title":"Clin Sci"},{"key":"R25-23-20250325","first-page":"F318","article-title":"PGE2 inhibits AVP\u2010induced water flow in cortical collecting ducts by protein kinase C activation","volume":"259","author":"H\u00e9bert","year":"1990","journal-title":"Am J Physiol"},{"key":"R26-23-20250325","first-page":"F555","article-title":"Mechanism of furosemide\u2010induced natriuresis by direct stimulation of renal prostaglandin E2","volume":"247","author":"Katayama","year":"1984","journal-title":"Am J Physiol"},{"key":"R27-23-20250325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00365520310008205","article-title":"Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study","volume":"39","author":"Guevara","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"R28-23-20250325","first-page":"309","article-title":"Role of prostaglandins and thromboxane in the control of renal hemodynamics in experimental liver cirrhosis","volume":"113","author":"Leehey","year":"1989","journal-title":"J Lab Clin Med"},{"key":"R29-23-20250325","first-page":"915","article-title":"Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis","volume":"22","author":"Ros","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R30-23-20250325","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R31-23-20250325","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/archinte.160.10.1465","article-title":"Effects of celecoxib and naproxen on renal function in the elderly","volume":"160","author":"Whelton","year":"2000","journal-title":"Arch Intern Med"},{"key":"R32-23-20250325","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)\u20102: the human pharmacology of a selective inhibitor of COX\u20102","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-23-20250325","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00542162","article-title":"Naproxen disposition in patients with alcoholic cirrhosis","volume":"27","author":"Williams","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"R34-23-20250325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/00912700022008766","article-title":"Effects of celecoxib, a novel cyclooxygenase\u20102 inhibitor, on platelet function in healthy adults: a randomized, controlled trial","volume":"40","author":"Leese","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"R35-23-20250325","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI110814","article-title":"Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man","volume":"71","author":"FitzGerald","year":"1983","journal-title":"J Clin Invest"},{"key":"R36-23-20250325","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/clpt.1983.220","article-title":"Responses to furosemide in normotensive and hypertensive subjects","volume":"34","author":"Wilson","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"R37-23-20250325","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","article-title":"Cyclooxygenase\u20102 is associated with the macula densa of rat kidney and increases with salt restriction","volume":"94","author":"Harris","year":"1994","journal-title":"J Clin Invest"},{"key":"R38-23-20250325","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2796.2003.01146.x","article-title":"Adverse renal effects of anti\u2010inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors","volume":"253","author":"Gambaro","year":"2003","journal-title":"J Int Med"},{"key":"R39-23-20250325","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.CIR.86.1.56","article-title":"Angioplasty triggers intracoronary leukotrienes and lipoxin A4: impact of aspirin therapy","volume":"86","author":"Brezinsky","year":"1992","journal-title":"Circulation"},{"key":"R40-23-20250325","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1054\/plef.2001.0275","article-title":"Effect of low\u2010dose aspirin in combination with stable fish oil on whole blood production of eicosanoids","volume":"64","author":"Engstr\u00f6m","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R41-23-20250325","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1089-3261(03)00022-9","article-title":"Hepatotoxicity associated with non\u2010steroidal anti\u2010inflammatory drugs","volume":"7","author":"Teoh","year":"2003","journal-title":"Clin Liver Dis"},{"key":"R42-23-20250325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00045391-200007030-00003","article-title":"The hepatic safety and tolerability of the novel cyclooxygenase\u20102 inhibitor celecoxib","volume":"7","author":"Maddrey","year":"2000","journal-title":"Am J Ther"},{"key":"R43-23-20250325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74867-4","article-title":"COX 2 inhibitor and fulminant hepatic failure","volume":"353","author":"McCormick","year":"1999","journal-title":"Lancet"},{"key":"R44-23-20250325","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/pmj.77.910.548","article-title":"Acute hepatocellular and cholestatic injury in a patient taking celecoxib","volume":"77","author":"Nachimuthu","year":"2001","journal-title":"Postgrad Med J"},{"key":"R45-23-20250325","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7326\/0003-4819-137-1-200207020-00030","article-title":"Celecoxib\u2010induced cholestatic hepatotoxicity in a patient with cirrhosis","volume":"137","author":"Alegria","year":"2002","journal-title":"Ann Intern Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20595","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200503000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T16:34:57Z","timestamp":1743093297000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200503000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20595","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}